Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

BACKGROUND: One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ peptide...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Res Ther
Egile Nagusiak: van Steenoven, Inger, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Lemstra, Afina W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788069/
https://ncbi.nlm.nih.gov/pubmed/31601267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0537-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak